Funding · Healthcare & Life Sciences
Oncare raises ₹27 crore in Series A round
By Startup Enthusiast ·
- Date
- Company
- Oncare
- What it does
- Distributed oncology care network
- Kind
- Funding
- Amount
- ₹27 Cr
- Stage
- Series A
- Founded
- 2023
What they do
Oncare runs a distributed oncology care model partnering with accredited hospitals
What happened
It raised ₹27 crore in Series A led by Sky Impact Capital with Huddle Ventures and others
Why it matters
The funds will expand into metro and Tier-2/3 cities and improve technology for patient care
The details
- Oncare raised ₹27 crore in a Series A funding round.
- The round was led by Sky Impact Capital.
- Participating investors included Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital.
- The company will use the funds to expand into metro markets and Tier-2/Tier-3 cities.
- It will also invest in technology to improve clinical operations, care coordination, and patient experience.
- Oncare operates a distributed oncology care model that partners with accredited hospitals.
- The model integrates medical, surgical, and radiation oncology services.
The bigger picture
- India's oncology care market is projected to reach ₹43,000 crore by FY28, growing at a CAGR of about 14%.
- Access to cancer treatment is uneven, with capacity concentrated in large hospitals.
- Indian healthtech startups raised nearly $700 million in 2025.
- Other funded oncology startups include 4baseCare, Everhope Oncology, and MOC Cancer Care.
About the business
- Oncare was founded in 2023 by Amar Sneh and Deepak Kumar.
- It operates four centres across Delhi NCR.
- The company uses a capex-light model to build a national oncology network.
- It focuses on affordable, standardised, and transparent cancer care.
- Oncare integrates with insurance to make treatment accessible.
- It partners with accredited hospitals to deliver care.
What happens next
- Expand into metro markets and Tier-2/Tier-3 cities.
- Invest in technology to improve clinical operations, care coordination, and patient experience.
The deal
- Type
- funding
Investors
- Sky Impact Capital (lead) — Investment firm focused on impact.
- Huddle Ventures (participated) — Venture capital firm.
- Lotus Herbal Group (participated)
- SteerX (participated)
- Tremis Capital (participated)
Founders
- Amar Sneh, Co-founder
- Deepak Kumar, Co-founder
About Oncare
- Product
- Integrated platform combining medical, surgical and radiation oncology services within accredited hospitals
- Customers
- Cancer patients seeking affordable and standardized treatment in metro and tier-2/tier-3 cities
- How it makes money
- B2B2C - partners with accredited hospitals to provide capital-efficient oncology services
- What sets it apart
- Distributed capital-efficient model avoiding large hospital infrastructure; integrated multi-specialty oncology services under one platform
- Operations
- Operating four centres across Delhi NCR; expanding into new metro markets, tier-2 and tier-3 cities
Other articles talking about it
Same day
- Bewakoof founder Prabhkiran Singh to step down24 February 2026 · People
- MobiKwik subsidiary cleared to start stock broking24 February 2026 · Launch
- GIVA’s loss widens 23% to ₹72.3 Cr in FY25 as revenue jumps 90%24 February 2026 · Results
- HireBound raises $2 million in seed funding led by Kalaari Capital24 February 2026 · Funding · $2 million
- Basil raises $2 million pre-Series A round24 February 2026 · Funding · $2 Mn
- Dhruva Space orders 14 thrusters from Exotrail24 February 2026 · Partnership